Article metrics

Download PDFPDF

Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA)

 

Online download statistics by month:

Online download statistics by month: February 2018 to October 2020

AbstractFullPdf
Feb 20181591557
Mar 201821121288
Apr 201811211132
May 201818218625
Jun 201815716112
Jul 2018646410
Aug 2018757214
Sep 2018484814
Oct 2018373714
Nov 2018434212
Dec 2018595716
Jan 2019211910
Feb 2019222317
Mar 2019606017
Apr 2019302922
May 2019404021
Jun 2019313115
Jul 2019383917
Aug 2019292914
Sep 2019212111
Oct 2019454320
Nov 201929296
Dec 201935336
Jan 202039399
Feb 202064648
Mar 2020363610
Apr 2020404014
May 2020474637
Jun 202024248
Jul 2020524321
Aug 2020454121
Sep 2020292711
Oct 2020403815
Total19641939574